Fecal calprotectin in patients with suspected colorectal cancer: A diagnostic accuracy study

30 Nov 2022

In this article, Alpha Laboratories describes a study that was undertaken to determine the diagnostic accuracy of fecal calprotectin in patients referred with suspected colorectal cancer, both for clinically significant colorectal neoplasia and for all organic enteric disease.

Links

Tags